Inhibikase Therapeutics Inc. (IKT)
NASDAQ · Healthcare
Inhibikase Therapeutics Inc. Shares Outstanding 2020–2024
Inhibikase Therapeutics Inc. annual/quarterly shares outstanding history and growth rate from 2020 to 2026. Shares outstanding refers to a company's stock currently held by all its shareholders, including institutional investors and company insiders.
- Inhibikase Therapeutics Inc. shares outstanding for the quarter ending March 31, 2026 was 0.17 B shs, a 92.44% increase year-over-year.
- Inhibikase Therapeutics Inc. annual shares outstanding for 2024 was 0.02 B shs, a 293.35% increase from 2023.
- Inhibikase Therapeutics Inc. annual shares outstanding for 2023 was 0.01 B shs, a 42.74% increase from 2022.
- Inhibikase Therapeutics Inc. annual shares outstanding for 2022 was 0.00 B shs, a 76.81% decrease from 2021.
- Inhibikase Therapeutics Inc. annual shares outstanding for 2021 was 0.02 B shs.
Shares Outstanding
ANNUAL · B SHS
QUARTERLY · B SHS
YEAR-OVER-YEAR GROWTH · %
Inhibikase Therapeutics Inc. Shares Outstanding — FAQ
Inhibikase Therapeutics Inc. (IKT) shares outstanding over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is Inhibikase Therapeutics Inc.'s shares outstanding?
Inhibikase Therapeutics Inc. (IKT) reported shares outstanding of 0.02B shares for fiscal 2024.
Where can I see IKT's shares outstanding history?
The chart and table above show Inhibikase Therapeutics Inc.'s shares outstanding by year and by quarter, including the growth rate.